中东和非洲基因分型市场预测至 2031 年 – 区域分析 – 按产品类型(仪器、试剂和试剂盒、生物信息学和基因分型服务)、技术(微阵列、毛细管电泳、测序、聚合酶链反应 (PCR)、基质辅助激光解吸/MALDI-TOF 和其他技术)、应用(药物基因组学、诊断和个性化医疗、动物遗传学、农业生物技术和其他应用)和最终用户(制药和生物制药公司、诊断和研究实验室、学术机构和其他最终用户)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031


No. of Pages: 151    |    Report Code: BMIRE00025970    |    Category: Life Sciences

Middle East & Africa Genotyping Market
2023 年中东和非洲基因分型市场价值为 12.1866 亿美元,预计到 2031 年将达到 42.7551 亿美元;预计 2023 年至 2031 年的复合年增长率为 17.0%。

个性化医疗日益普及,促进了中东和非洲基因分型市场的发展

根据英国国家医疗服务体系 (NHS) 的数据,个性化医疗是根据每位患者的独特特征量身定制的医疗方法。该方法基于科学进步,可以了解一个人独特的基因和分子特征,这有助于他们易患疾病,并有助于确定最安全和最有效的医疗方法。基因组医学以每个人独特的基因、临床和环境信息为指导,是个性化医疗的基本组成部分。个性化医疗的基础包括将各种基本工具标准化、开发和集成到卫生系统和临床工作流程中,用于转录、序列变异、蛋白质和代谢物的全基因组研究。健康风险评估、家族健康史和复杂风险和预测信息的临床决策辅助与基因组数据相结合,以检测个体风险并指导临床治疗,为更明智、更有效的患者护理方法奠定基础。

基于 DNA 的常见复杂疾病风险评估、基因组引导治疗、剂量选择和癌症诊断和预后的分子特征是基因组信息已经实现个性化医疗保健的例子。个性化医疗与医疗保健的结合可以帮助更精确地诊断,在症状出现之前预测疾病风险,并提供具有最大安全性和效率的个性化治疗计划。基因型数据可用作确定正确华法林剂量的指南。临床药物基因组学实施联盟已经制定了基于基因型的药物指南,以协助医生根据基因测试结果优化药物疗法。肿瘤基因组分析有助于为患有遗传性癌症的个体量身定制治疗方法。

尽管与个性化医疗相关的科学发现正在从实验室走向诊所,但个性化医疗的广泛接受需要在监管、报销程序和立法隐私法方面做出重大改变,以便迅速采用这些药物。因此,由于正在进行的研究和使用基因组编辑技术,个性化医疗的知名度和普及度不断提高,预计将成为基因分型市场增长的趋势。

中东和非洲基因分型市场概述

中东和非洲基因分型市场的增长归因于医疗设施的重大进步、机器人在治疗中的高采用率以及市场参与者的地理扩张努力等因素。此外,癌症发病率的上升、一些私人和政府机构对医疗保健领域的投资不断增加以及与发达地区医院的合作日益增多,预计将在预测期内推动中东和非洲基因分型市场的增长。

中东和非洲基因分型市场收入及预测至 2031 年(百万美元)

中东和非洲基因分型市场细分

中东和非洲基因分型市场分为产品、技术、应用、最终用户和国家。

根据产品,中东和非洲基因分型市场细分为仪器、试剂和试剂盒、生物信息学和基因分型服务。试剂和试剂盒部分在 2023 年占据最大市场份额。

按技术,中东和非洲基因分型市场细分为微阵列、毛细管电泳、测序、聚合酶链反应 (PCR)、基质辅助激光解吸/MALDI-TOF 和其他技术。聚合酶链反应 (PCR) 细分市场在 2023 年占据最大市场份额。

根据应用,中东和非洲基因分型市场分为药物基因组学、诊断和个性化医疗、动物遗传学、农业生物技术和其他应用。诊断和个性化医疗细分市场在 2023 年占据最大市场份额。

就最终用户而言,中东和非洲基因分型市场分为制药和生物制药公司、诊断和研究实验室、学术机构和其他最终用户。制药和生物制药公司细分市场在 2023 年占据最大市场份额。

根据分销渠道,中东和非洲基因分型市场分为药店、零售店和在线。 2023 年,药店部门占据了最大的市场份额。

按国家/地区划分,中东和非洲基因分型市场细分为沙特阿拉伯、南非、阿联酋和中东及非洲其他地区。2023 年,沙特阿拉伯占据了中东和非洲基因分型市场的主导份额。

Hoffmann-La Roche Ltd、QIAGEN NV、Merck KGaA、Thermo Fisher Scientific Inc、BioTek Instruments Inc、Illumina Inc、Danaher Corp、Bio-Rad Laboratories Inc、GE HealthCare Technologies Inc、Standard BioTools Inc、Laboratory Corp of America Holdings、Beckman Coulter Inc、BGI、Takara Bio Inc 和 DiaSorin SpA 是中东和非洲基因分型市场的主要公司。

Middle East & Africa Genotyping Strategic Insights

Strategic insights for Middle East & Africa Genotyping involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-genotyping-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Genotyping Report Scope

Report Attribute Details
Market size in 2023 US$ 1,218.66 Million
Market Size by 2031 US$ 4,275.51 Million
Global CAGR (2023 - 2031) 17.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 产品类型
  • 仪器
  • 试剂和试剂盒
  • 生物信息学
  • 基因分型服务
By 技术
  • 微阵列
  • 毛细管电泳
  • 测序
  • 聚合酶链式反应
  • 基质辅助激光解吸/MALDI-TOF
  • 其他技术
By 应用
  • 药物基因组学
  • 诊断和个性化医疗
  • 动物遗传学
  • 农业生物技术
  • 其他应用
By 最终用户
  • 制药和生物制药公司
  • 诊断和研究实验室
  • 学术机构
  • 其他最终用户
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Hoffmann-La Roche Ltd.
  • QIAGEN NV.
  • Merck KGaA.
  • Thermo Fisher Scientific Inc.
  • BioTek Instruments, Inc.
  • Illumina Inc.
  • Danaher Corp.
  • Bio-Rad Laboratories Inc.
  • GE HealthCare Technologies Inc.
  • Standard BioTools Inc.
  • Get more information on this report

    Middle East & Africa Genotyping Regional Insights

    The regional scope of Middle East & Africa Genotyping refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-genotyping-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Genotyping Market

    • Hoffmann-La Roche Ltd.
    • QIAGEN NV.
    • Merck KGaA.
    • Thermo Fisher Scientific Inc.
    • BioTek Instruments, Inc.
    • Illumina Inc.
    • Danaher Corp.
    • Bio-Rad Laboratories Inc.
    • GE HealthCare Technologies Inc.
    • Standard BioTools Inc.
    • Laboratory Corp of America Holdings.
    • Beckman Coulter Inc.
    • BGI.
    • Takara Bio Inc.
    • DiaSorin SpA.
    Frequently Asked Questions
    How big is the Middle East & Africa Genotyping Market?

    The Middle East & Africa Genotyping Market is valued at US$ 1,218.66 Million in 2023, it is projected to reach US$ 4,275.51 Million by 2031.

    What is the CAGR for Middle East & Africa Genotyping Market by (2023 - 2031)?

    As per our report Middle East & Africa Genotyping Market, the market size is valued at US$ 1,218.66 Million in 2023, projecting it to reach US$ 4,275.51 Million by 2031. This translates to a CAGR of approximately 17.0% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Genotyping Market report typically cover these key segments-

  • 产品类型 (仪器, 试剂和试剂盒, 生物信息学, 基因分型服务)
  • 技术 (微阵列, 毛细管电泳, 测序, 聚合酶链式反应, 基质辅助激光解吸/MALDI-TOF, 其他技术)
  • 应用 (药物基因组学, 诊断和个性化医疗, 动物遗传学, 农业生物技术, 其他应用)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Genotyping Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Genotyping Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in Middle East & Africa Genotyping Market?

    The Middle East & Africa Genotyping Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Hoffmann-La Roche Ltd.
  • QIAGEN NV.
  • Merck KGaA.
  • Thermo Fisher Scientific Inc.
  • BioTek Instruments, Inc.
  • Illumina Inc.
  • Danaher Corp.
  • Bio-Rad Laboratories Inc.
  • GE HealthCare Technologies Inc.
  • Standard BioTools Inc.
  • Laboratory Corp of America Holdings.
  • Beckman Coulter Inc.
  • BGI.
  • Takara Bio Inc.
  • DiaSorin SpA.
  • Who should buy this report?

    The Middle East & Africa Genotyping Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Genotyping Market value chain can benefit from the information contained in a comprehensive market report.